Most of the drugs in the market are originated -directly or indirectly- from natural resources such as chloroquine, digoxin, hyoscine and Taxol. Lots of reported data discuss the in vitro and in vivo biological activities of natural extracts and isolated compounds, therefore the lights should be shed on the preclinical and clinical studies of these products in an attempt to add a new building block to the field of drug discovery. Choosing the extracts or compounds for clinical trials should depend on the availability of their natural sources as well as the yield in case of isolated compounds.

References

1. Al-Sayed E., et al. “Anti-inflammatory and analgesic activities of cupressuflavone from Cupressus macrocarpa: Impact on pro-inflammatory mediators”. Drug Development Research1 (2018): 22-28.
2. Dumitru G., et al. “Agathisflavone isolated from Schinus polygamus (Cav.) Cabrera leaves prevents scopolamine-induced memory impairment and brain oxidative stress in zebrafish (Danio rerio)”. Phytomedicine 9 (2019): 4457-4468.
3. Abd El-Ghffar EA., et al. “The protective role of Ocimum basilicum (Basil) against aspirin-induced gastric ulcer in mice: Impact on oxidative stress, inflammation, motor deficits and anxiety-like behavior”. Food and Function 9.8 (2018): 4457-4468.
4. Nayim P., et al. “Antibacterial and Antibiotic-Potentiating Activities of Thirteen Cameroonian Edible Plants against Gram-Negative Resistant Phenotypes”. Scientific World Journal 10 (2018): 4020294.

Citation

Citation: Ahmed M Abd-Alkhalek and Omayma A Eldahshan. “Natural Products for Drug Discovery".Acta Scientific Pharmacology 1.8 (2020): 01-02.

Copyright

Copyright: © 2020 Ahmed M Abd-Alkhalek and Omayma A Eldahshan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.